Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_assertion type Assertion NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_head.
- NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_assertion wasGeneratedBy ECO_0000203 NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_provenance.
- NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_assertion wasDerivedFrom befree-2016 NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_provenance.
- NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_assertion SIO_000772 10690891 NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_provenance.
- NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_assertion evidence source_evidence_literature NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_provenance.
- NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_assertion description "[Recently, studies using somatostatin (SRIF) analogs preferential for either the SRIF receptor 2 (SSTR2) or the SSTR5 subtype demonstrated a variable suppression of GH and PRL release from GH-secreting human adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP276256.RAco3YwtoP-HZBUQ3jnw-he_JA__4S8sqTWMhBsVDEGFE130_provenance.